news, journals and articles from all over the world.
2021 ARRS Virtual Annual Meeting Scientific Electronic Exhibit found no statistically significant threshold for increased renal transplant biopsy risk based on systolic, diastolic, or mean arterial blood pressure alone
Read moreTwo new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.
Read moreWatch live and recorded press conferences at http://www. acs. org/ acsspring2021conferences . Press conferences will be held Monday, April 5,
Read moreTwo new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic
Read moreResearchers at Children’s Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A. The target, known as B cell activating factor (BAFF), appears to promote antibodies against and inhibitors of the missing blood clotting factor that is given to these patients to control their bleeding episodes. The findings, published in the Journal of Clinical Investigation, raise the possibility of using anti-BAFF therapies, potentially in combination with immune tolerance therapies, to tame the immune response in some patients with severe hemophilia A.
Read moreJames P. Allison, PhD, Carl H. June, MD and Siddhartha Mukherjee, MD Keynote April 29 Summit
Read morePilot study suggests nutrition improves success of pediatric leukemia treatment; national trial to launch this year
Read moreGroundbreaking identification of precocious clonal hematopoiesis unlocks new lines of research and discovery for scientists
Read moreOctaplas™ and fibryga® receive new product labeling following FDA’s approval of BLA supplements to update therapy research; FDA expands fibryga® indication to include treatment of children under 12 years of age
Read moreSensitive test opens door to personalized therapy
Read moreProject aims to develop improved predictive and detection tools for kidney injury
Read more
Cecelia Calhoun, MD, MSPH, MBA, has been appointed Assistant Professor of Medicine (Hematology) and Assistant Professor of Pediatrics (Hematology/Oncology) at Yale Cancer Center and Smilow Cancer Hospital
Read moreDespite guidelines promoting outpatient management of patients with low-risk pulmonary embolism (PE), few patients are currently discharged home from hospital
Read moreMyelodysplastic syndrome (MDS) is a disease of the stem cells in the bone marrow, which disturbs the maturing and differentiation
Read morePhase III study shows benefits of using age and functional status to guide, modify treatment approach
Read moreCellular engineering makes it possible to target the therapy also against solid tumors
Read moreJoin world renowned cancer researchers as they gather to discuss latest advances in cancer cell and gene therapy for solid tumors
Read moreFindings enhance our understanding of the importance of ribosome assembly in stem cell regeneration and potential therapeutic strategies for ribosomopathies, which lead to pediatric bone marrow abnormalities
Read moreAtherosclerosis is the underlying condition that causes heart attacks and strokes. Researchers at Radboudumc in the Netherlands have discovered a
Read moreResearch demonstrates potential for rapid, accurate glycan sequencing
Read moreAs researchers around the world work to identify and address risk factors for severe COVID-19, there is additional evidence that
Read moreResearchers determine the reason for the ineffectiveness of current drug therapies in restoring the immune system of some HIV patients
Read moreNew clinical practice guidelines from National Comprehensive Cancer Network focus on workup and management for three main adult histiocytic disorders.
Read moreIn the KarMMa trial, ide-cel produces remissions in almost 75% of patients who had relapsed after several previous treatments; Trial results spur application for FDA approval of therapy for patients with relapsed/resistant myeloma
Read moreA chip-based, microfluidic, AI-powered diagnostic platform could make medical diagnostics more affordable, accessible.
Read moreAdvances in hydrogel wound dressings make them antibacterial, biodegradable, better suited for healing irregular, deep wounds
Read moreUsing advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present in many patients with Acute
Read moreScientists offered a new method for treating leukemia using nanomaterials
Read moreOne of the many mysteries still surrounding COVID-19 is why some people experience only mild, flu-like symptoms, whereas others suffer
Read moreHebrew University researchers advance simple and inexpensive diagnostic blood test
Read moreRCSI University of Medicine and Health Sciences has received a €1.3 million grant from Wellcome to further develop a blood
Read moreAmong 3,239 critically ill adults with COVID-19, early use of therapeutic anticoagulation in the intensive care unit did not reduce the risk of death, an observational study found
Read moreTechnology based on nanoparticles identifies IgG antibodies and costs only about a fifth of similar devices now on the market. It was developed by scientists at the University of São Paulo and Brazilian startup Biolinker.
Read moreBottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends against screening for asymptomatic carotid artery stenosis in the general adult
Read moreNew research has found that men who have the Western world’s most common genetic disorder are more likely to develop
Read moreNew preclinical study shows vector results in significantly more hemoglobin production than vectors currently used in gene therapy for sickle cell disease and beta-thalassemia
Read moreWhat The Study Did: Maternally derived antibodies are a key element of neonatal immunity. This study examined the association between maternal
Read more
Viral infections and space travel similarly trigger inflammation and the enzymes APOBEC3C and ADAR1; UC San Diego researchers are developing ways to inhibit them as a means to potentially lower cancer risk for both astronauts and people on Earth.
Read more
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
Read moreFor the first time, scientists watch fibroblasts, key cell type involved in wound healing, coordinate closure of damaged vascularized tissue
Read moreThe American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World
Read moreNew NCCN guidelines for patients: Survivorship series provides expert advice to help cancer survivors sustain better health while monitoring for any long-term side effects or recurrences
Read moreOne of the physiopathological characteristics of COVID-19 that has most baffled the scientific and medical community is what is known as “silent hypoxemia” or “happy hypoxia”.
Read moreLimited rejuvenation of aged hematopoietic stem cells in young bone marrow niche
Read moreThe ASH Research Collaborative and International Society on Thrombosis and Haemostasis define thrombosis-related endpoints to inform COVID-19 clinical trial design
Read moreCleveland Clinic research team publishes findings in Blood Cancer Discovery
Read moreSysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, will be exhibiting virtually at the 72nd AACC Annual Scientific Meeting & Clinical Lab Expo, December 14 – 17.
Read more
In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphocytic leukaemia.
Read morePeer Reviewed – Survey – Humans
Read moreProtein therapies are often more potent and selective toward their biochemical targets than other types of drugs, particularly small molecules.
Read more